WHAT TO KNOW ABOUT GERD


GASTROESOPHAGEAL REFLUX DISEASE (GERD) icon

GASTROESOPHAGEAL REFLUX DISEASE (GERD)

GERD is a chronic disease that happens when stomach acid flows into the esophagus and causes irritation. Two main types of GERD are Non-Erosive GERD and Erosive Esophagitis (EE).

Who does GERD affect?

approximately 65 million people in the US have GERD

GERD is one of the most common digestive diseases, affecting approximately 65 million people in the United States.

approximately 65 million people in the US have GERD

EROSIVE ESOPHAGITIS (EE) VS NON-EROSIVE GERD

2/3 of people living with GERD have non-erosive GERD

EE is a type of GERD in which acid-related damage to the esophagus occurs. Non-Erosive GERD does not involve damage to the esophagus and is more common. Heartburn is common in both conditions.

2/3 of people living with GERD have non-erosive GERD

HEARTBURN THAT PERSISTS

58% of people suffering from EE still experience heartburn while on their treatment

Many people with EE continue to feel acid in their esophagus despite taking medicines such as antacids, histamine-2 receptor antagonists (H2s), or proton pump inhibitors (PPIs).

58% of people suffering from EE still experience heartburn while on their treatment

AVAILABLE TREATMENTS FOR GERD

Not all treatments work for everyone. It’s important to talk to your doctor about treatments that are right for you. If you think you might have GERD, know that you’re not alone.

the history of GERD timeline icon

The first antacid was approved for use

Antacids neutralize the acid in your stomach to help relieve heartburn. They are typically offered over the counter and are used for symptom relief.


the history of GERD timeline icon

The first histamine-2 receptor antagonist (H2) was approved for use

H2s reduce the amount of acid produced in the stomach by blocking one of the first steps in acid production. H2s treat heartburn symptoms related to GERD.


the history of GERD timeline icon

The first proton pump inhibitor (PPI) was approved for use

PPIs are a common treatment for GERD. They treat GERD by blocking the final step of acid production. They are activated by stomach acid and most PPIs must be taken 30-60 minutes prior to meals.


the history of GERD timeline icon

VOQUEZNA (vonoprazan) was approved for use as the first potassium-competitive acid blocker

VOQUEZNA was approved as the first potassium-competitive acid blocker (PCAB) to treat EE and its symptoms in 2023 and later to relieve heartburn caused by Non-Erosive GERD in 2024. PCABs work by blocking the final step of acid production—they do not need to be activated by stomach acid and can be taken with or without food.

GASTROESOPHAGEAL REFLUX DISEASE (GERD) icon

FACTORS THAT MAY INCREASE YOUR CHANCES OF DEVELOPING GERD INCLUDE:

  • Hiatal hernia
  • Obesity
  • Lower esophageal sphincter doesn‘t close correctly
  • Delayed stomach emptying
symptoms related to GERD icon

SYMPTOMS RELATED TO GERD

The most common symptoms are heartburn and acid regurgitation. Other possible symptoms include:

  • Difficult or painful swallowing
  • Chronic cough
  • Chest pain
endoscopy icon

HOW IS GERD DIAGNOSED?

To diagnose GERD, your doctor will ask you a few questions, and may perform a physical exam. To diagnose EE, an endoscopy is needed. An endoscopy is a procedure in which a thin tube equipped with a tiny camera is lowered down your throat.

symptoms of Erosive Esophagitis icon

Talk to your doctor
about a different option

symptoms of Erosive Esophagitis icon

If you’re still searching for a way to control Non-Erosive GERD or EE, use our doctor discussion guide to help talk to your doctor about VOQUEZNA.